IgE Effector Mechanisms, in Concert with Mast Cells, Contribute to Acquired Host Defense against Staphylococcusaureus.


Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
13 10 2020
Historique:
received: 21 10 2019
revised: 02 06 2020
accepted: 06 08 2020
pubmed: 11 9 2020
medline: 20 4 2021
entrez: 10 9 2020
Statut: ppublish

Résumé

Allergies are considered to represent mal-directed type 2 immune responses against mostly innocuous exogenous compounds. Immunoglobulin E (IgE) antibodies are a characteristic feature of allergies and mediate hypersensitivity against allergens through activation of effector cells, particularly mast cells (MCs). Although the physiological functions of this dangerous branch of immunity have remained enigmatic, recent evidence shows that allergic immune reactions can help to protect against the toxicity of venoms. Because bacteria are a potent alternative source of toxins, we assessed the possible role of allergy-like type 2 immunity in antibacterial host defense. We discovered that the adaptive immune response against Staphylococcus aureus (SA) skin infection substantially improved systemic host defense against secondary SA infections in mice. Moreover, this acquired protection depended on IgE effector mechanisms and MCs. Importantly, our results reveal a previously unknown physiological function of allergic immune responses, IgE antibodies, and MCs in host defense against a pathogenic bacterium.

Identifiants

pubmed: 32910906
pii: S1074-7613(20)30335-6
doi: 10.1016/j.immuni.2020.08.002
pmc: PMC7572876
mid: NIHMS1627765
pii:
doi:

Substances chimiques

Allergens 0
Immunoglobulin E 37341-29-0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

793-804.e9

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI132494
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI023990
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR067145
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI070813
Pays : United States
Organisme : Austrian Science Fund FWF
ID : P 31113
Pays : Austria

Commentaires et corrections

Type : CommentIn
Type : ErratumIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Références

Immunol Rev. 2015 Nov;268(1):25-51
pubmed: 26497511
Nat Med. 2011 Sep 18;17(10):1310-4
pubmed: 21926978
Am J Respir Crit Care Med. 2010 Apr 15;181(8):782-7
pubmed: 20382801
Cell. 2014 Jun 5;157(6):1309-1323
pubmed: 24906149
Immunity. 2019 Mar 19;50(3):552-565
pubmed: 30893586
Immunity. 2015 Jul 21;43(1):29-40
pubmed: 26200011
J Leukoc Biol. 2006 Oct;80(4):816-26
pubmed: 16864603
Eur J Immunol. 2019 Sep;49(9):1334-1343
pubmed: 31355918
Eur Respir J. 2019 Sep 12;54(3):
pubmed: 31285304
Virulence. 2018 Jan 1;9(1):231-247
pubmed: 29099326
Microb Pathog. 2013 Oct;63:24-9
pubmed: 23747685
Q Rev Biol. 1991 Mar;66(1):23-62
pubmed: 2052671
J Clin Invest. 2016 Dec 1;126(12):4497-4515
pubmed: 27820702
BMC Bioinformatics. 2009 Feb 03;10:48
pubmed: 19192299
Pharmacol Ther. 2018 Nov;191:50-64
pubmed: 29909239
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Immunol Rev. 2018 Mar;282(1):188-197
pubmed: 29431211
Clin Infect Dis. 2008 Jun 1;46 Suppl 5:S368-77
pubmed: 18462092
J Allergy Clin Immunol. 2017 Aug;140(2):335-348
pubmed: 28780941
J Immunol. 2008 Apr 1;180(7):4742-53
pubmed: 18354198
Nat Immunol. 2011 Jun;12(6):527-35
pubmed: 21552267
Immunol Rev. 2018 Mar;282(1):87-113
pubmed: 29431205
Allergy Asthma Immunol Res. 2019 Sep;11(5):593-603
pubmed: 31332972
Sci Rep. 2017 Dec 4;7(1):16878
pubmed: 29203879
Sci Immunol. 2018 Jul 6;3(25):
pubmed: 29980619
Nat Rev Immunol. 2014 Jul;14(7):478-94
pubmed: 24903914
J Clin Invest. 2011 Oct;121(10):4180-91
pubmed: 21926462
Curr Opin Microbiol. 2015 Feb;23:42-8
pubmed: 25461571
Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2272-2274
pubmed: 29476009
Nat Rev Immunol. 2013 May;13(5):362-75
pubmed: 23558889
Cell. 1994 Feb 11;76(3):519-29
pubmed: 8313472
Mol Cell Proteomics. 2005 Dec;4(12):2010-21
pubmed: 16249172
Nat Rev Immunol. 2020 Oct;20(10):603-614
pubmed: 32367051
Proc Natl Acad Sci U S A. 2015 Nov 17;112(46):14337-42
pubmed: 26489655
J Allergy Clin Immunol. 2016 Jun;137(6):1631-1645
pubmed: 27263999
J Allergy Clin Immunol. 2016 Jan;137(1):246-257.e11
pubmed: 26410782
Immunity. 2013 Nov 14;39(5):976-85
pubmed: 24210353
Infect Immun. 2013 Apr;81(4):1306-15
pubmed: 23381997
N Engl J Med. 2014 Oct 23;371(17):1619-28
pubmed: 25337751
Nat Protoc. 2018 Mar;13(3):530-550
pubmed: 29446774
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Curr Opin Microbiol. 2014 Feb;17:32-7
pubmed: 24581690
J Allergy Clin Immunol. 2004 Oct;114(4):981-3
pubmed: 15480349
Immunity. 2018 Feb 20;48(2):396
pubmed: 29466760
J Immunol. 1980 Jun;124(6):2728-37
pubmed: 7373045
Nat Med. 2012 May 04;18(5):693-704
pubmed: 22561833
Transgenic Res. 2008 Apr;17(2):307-15
pubmed: 17972156
Front Immunol. 2018 Jul 09;9:1532
pubmed: 30038613
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
Immunol Rev. 2018 Mar;282(1):121-150
pubmed: 29431212
Cell. 1993 Dec 3;75(5):969-76
pubmed: 8252632
Nature. 1994 Aug 4;370(6488):367-70
pubmed: 8047141
Mol Syst Biol. 2014 Oct 30;10:757
pubmed: 25358341
PLoS One. 2010 Dec 02;5(12):e14210
pubmed: 21151984
Immunity. 2013 Nov 14;39(5):963-75
pubmed: 24210352
Lancet. 2006 Mar 4;367(9512):731-9
pubmed: 16517273
Semin Immunopathol. 2016 Sep;38(5):581-603
pubmed: 27225312
Nature. 2013 Nov 21;503(7476):397-401
pubmed: 24172897
Sci Adv. 2019 Jan 02;5(1):eaav0216
pubmed: 30613778
Nat Rev Immunol. 2016 Aug;16(8):524-32
pubmed: 27396446
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):698-706
pubmed: 23703488
J Allergy Clin Immunol. 2017 Feb;139(2):492-500.e8
pubmed: 27315768
MAbs. 2016 Oct;8(7):1347-1360
pubmed: 27467113
J Exp Med. 2007 Oct 29;204(11):2629-39
pubmed: 17923505
Nature. 2012 Apr 25;484(7395):465-72
pubmed: 22538607
PLoS Pathog. 2017 Sep 21;13(9):e1006452
pubmed: 28934339
Cell Host Microbe. 2019 Jul 10;26(1):114-122.e8
pubmed: 31278040
Allergy. 2017 May;72(5):754-763
pubmed: 27753449
Science. 2019 Aug 30;365(6456):
pubmed: 31371561
Science. 2006 Jul 28;313(5786):526-30
pubmed: 16873664

Auteurs

Philipp Starkl (P)

CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria; Laboratory of Infection Biology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305-5176, USA. Electronic address: philipp.starkl@meduniwien.ac.at.

Martin L Watzenboeck (ML)

CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria; Laboratory of Infection Biology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.

Lauren M Popov (LM)

Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305-5176, USA; Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA.

Sophie Zahalka (S)

CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria; Laboratory of Infection Biology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.

Anastasiya Hladik (A)

CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria; Laboratory of Infection Biology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.

Karin Lakovits (K)

CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria; Laboratory of Infection Biology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.

Mariem Radhouani (M)

CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria; Laboratory of Infection Biology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.

Arvand Haschemi (A)

Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria.

Thomas Marichal (T)

Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305-5176, USA; GIGA-Research and Faculty of Veterinary Medicine, University of Liege, 4000 Liege, Belgium.

Laurent L Reber (LL)

Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305-5176, USA; Center for Physiopathology of Toulouse-Purpan (CPTP), UMR 1043, University of Toulouse, INSERM, CNRS, 31024 Toulouse, France.

Nicolas Gaudenzio (N)

Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305-5176, USA; Unité de Différenciation Epithéliale et Autoimmunité Rhumatoïde (UDEAR), UMR 1056, INSERM, Université de Toulouse, 31059 Toulouse, France.

Riccardo Sibilano (R)

Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305-5176, USA; Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, CA 94305-5176, USA.

Lukas Stulik (L)

X4 Pharmaceuticals (Austria) GmbH, 1030 Vienna, Austria.

Frédéric Fontaine (F)

Laboratory of Infection Biology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.

André C Mueller (AC)

Laboratory of Infection Biology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.

Manuel R Amieva (MR)

Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305-5176, USA; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305-5176, USA.

Stephen J Galli (SJ)

Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305-5176, USA; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305-5176, USA; Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, CA 94305-5176, USA. Electronic address: sgalli@stanford.edu.

Sylvia Knapp (S)

CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria; Laboratory of Infection Biology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria. Electronic address: sylvia.knapp@meduniwien.ac.at.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH